A rubella serosurvey in postpartum women in the three regions of Peru

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 22, Issue 2, 2007, Pages 110-117

  Suárez Ognio, Luis ^a   Adrianzén, Ana ^a   Ortiz, Ana ^b   Martínez, Carlos ^a   Whittembury, Alvaro ^a   Cabezudo, Edwin ^b   De Oliveira, Lucia ^c   Siqueira, Marilda M ^d   Castillo Solórzano, Carlos ^e  

^a MINISTERIO DE SALUD   (Peru)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c PAN AMERICAN HEALTH ORGANIZATION   (Peru)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

Congenital; Disease susceptibility; Immunization; Peru; Rubella; Rubella syndrome; Seroepidemiologic studies

Indexed keywords

ANTIBODY; HEALTH SURVEY; MULTIVARIATE ANALYSIS; QUESTIONNAIRE SURVEY; RUBELLA; SERUM; WOMENS HEALTH;

PERU; SOUTH AMERICA;

RUBELLA;

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONGENITAL RUBELLA SYNDROME; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; EVALUATION; FEMALE; HUMAN; IMMUNOLOGY; INFORMATION PROCESSING; INFORMED CONSENT; MIDDLE AGED; PERU; PREGNANCY; PUERPERIUM; RISK; RISK FACTOR; RUBELLA; RUBELLA VIRUS; SOCIOECONOMICS; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFORMED CONSENT; MIDDLE AGED; ODDS RATIO; PERU; POSTPARTUM PERIOD; PREGNANCY; RISK FACTORS; RUBELLA; RUBELLA SYNDROME, CONGENITAL; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS;

EID: 36448937506     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892007000700005     Document Type: Article

References (25)

1. Chin J, ed. El control de las enfermedades transmisibles. 17th ed. Washington, D.C.: Organización Panamericana de la Salud; 2001. (Publicación Científica y Técnica No. 581).
2. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust. 1941;3:35-46.
3. World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2000;20(75):161-72.
4. Perú, Ministerio de Salud, Oficina General de Epidemiologí a, Dirección Ejecutiva de Vigilancia Epidemiológica. Measles Elimination Surveillance System. [Electronic database, updated weekly], Lima: Ministerio de Salud; 2003.
5. Blitchtein-Winicki D, Silva N, Narváez M, Gonzáles J, Gonzáles M, Del Águila R, et al. Síndrome de rubéola congénita en 6 colegios para niños con sordera y/o ceguera en Lima, Cusco y Arequipa, Perú, 1998-2000. An Fac Med Lima. 2002;63(2):93-100.
6. Blitchtein-Winicki D, Gonzáles P, Rodríguez R, Matos J, Santillán M, Soto C, et al. Síndrome de rubéola congénita en diecisiete hospitales del Perú, 1998-2000. An Fac Med Lima. 2002;63(3):171-8.
7. Perú, Ministerio de Salud, Oficina de Epidemiología, Dirección Ejecutiva de Vigilancia Epidemiológica. Noti v 3.1 [Electronic database, updated weekly]. Lima: Ministerio de Salud; 2005.
8. Evans AS. Surveillance and seroepidemiology. In: Evans AS, ed. Human viral infertion. New York: Plenum Press; 1989. Pp. 51-73.
9. Cutts F, Robertson SE, Diaz-Ortega J, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS. Bull World Health Organ. 1997;75(1):55-68.
10. Dowdle WR, Ferreira W, De Salles Gomes LF, King D, Kourany M Madalengoita J, et al. WHO collaborative study on the seroepidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ. 1970;42:419-22.
11. Desinor OY, Anselme RJP, Lender F, SaintLouis C, Bien-Aime JE. Seroprevalence of antibodies against rubella virus in pregnant women in Haiti. Rev Panam Salud Publica. 2004;15(3):147-50.
12. Tapia-Conyer R, Sepúlveda J, Salvatierra B, Muñoz O, Bustamante-Calvillo ME, Alvarez y Muñoz MT, et al. Factores determinantes de la rubéola en pobladón de 10 a 14 años de edad en México. Salud Publica Mex. 1992;34: 211-21.
13. Martín-Sosa S, Magaña M. Encuesta de anticuerpos contra la rubéola en estudiantes universitarias. Bol Med Hosp Infant Mex. 1974; 31(6):1165-70.
14. Villasís-Keever M, Peña L, Miranda-Novales G, Alvarez y Muñoz T, Damasio-Santana L, López-Fuentes G, et al. Prevalence of serological markers against measles, rubella, varicella, hepatitis B, hepatitis C, and human immunodeficiency virus among medical residents in Mexico. Prev Med. 2001;32(5): 424-8.
15. Vijayalakshmi P, Anuradha R, Prakash K, Narendan K, Ravindran M, Prajna L, et al. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India. Bull World Health Organ. 2004;82(4):259-64.
16. Brotherton J, Bartlett M, Muscatello D, Campbell-Lloyd S, Stewart K, McAnulty JM. Do we prartice what we preach? Health care worker screening and vaccination. Am J Infect Control. 2003;31(3):144-50.
17. Díaz MP. Prevalencia de anticuerpos IgG contra el virus de la rubéola en gestantes en el Hospital Nacional Cayetano Heredia, marzo 1998 [thesis]. Lima: Universidad Peruana Cayetano Heredia; 1998.
18. Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis. 2003;187 Suppl 15146-52.
19. Hinman AR. Rubella and the Americas. Rev Panam Salud Publica. 2003;14(5):298-9.
20. Organización Panamericana de la Salud. Nueva meta de los programas de vacunación en la Región de las Américas: eliminar la rubéola y el síndrome de rubéola congénita. Rev Panam Salud Publica. 2003;14(5):359-63.
21. Andrus JK, Periago MR. Elimination of rubella and congenital rubella syndrome in the Americas: another opportunity to address inequities in health. Rev Panam Salud Publica. 2004;15(3):145-6.
22. Cutts FT, Best J, Siqueira MM, Engstrom K, Robertson SE. Guidelines for surveillance of congenital rubella syndrome and rubella. Field test version, May 1999. Geneva: World Health Organization; 1999.
23. Perú, Fondo Nacional de Compensadón y Desarrollo Nadonal. El mapa de pobreza 2000. Principales indicadores que definen el estado de vida. Lima: FONCODES; 2000.
24. Public Health Burden of Rubella and CRS. Expanded Program on Immunization in the Americas. Immunize and protect your children. EPI Newsletter. 1998;20(4):2-3.
25. Perú, Ministerio de Salud, Oficina General de Epidemiologí a. La mortalidad materna en el Perú. Lima: Ministerio de Salud; 2003.